








tTitle:  MMR deficiency does not sensitize or compromise the function of hematopoietic stem cells to low 
and high LET radiation.  
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One of the major health concerns on long-duration space missions will be radiation exposure to the 
astronauts. Outside the earth’s magnetosphere, astronauts will be exposed to galactic cosmic rays (GCR) 
and solar particle events (SPE) that are principally composed of protons and He, Ca, O, Ne, Si, Ca, and Fe 
nuclei.  Protons are by far the most common species, but the higher atomic number particles are 
thought to be more damaging to biological systems. Evaluation and amelioration of risks from GCR 
exposure will be important for deep space travel.  The hematopoietic system is one of the most 
radiation-sensitive organ systems, and is highly dependent on functional DNA repair pathways for 
survival.  Recent results from our group have demonstrated an acquired deficiency in mismatch repair 
(MMR) in human hematopoietic stem cells (HSCs) with age due to functional loss of the MLH1 protein, 
suggesting an additional risk to astronauts who may have significant numbers of MMR deficient HSCs at 
the time of space travel.  In the present study, we investigated the effects gamma radiation, proton 
radiation, and 
56




 marrow from mice in a variety of 
assays and have determined that while cosmic radiation is a major risk to the hematopoietic system, 
there is no dependence on MMR capacity. 
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Exposure to ionizing radiation (IR) is considered to be one of the major risk factors during space 
activities, especially long-duration space missions [1, 2]. Astronauts on missions to the International 
Space Station, the moon, or Mars will be exposed to IR with effective total doses in the range of 5 to 200 
cGy (centigray) based on projected mission scenarios [3, 4].The primary components of space radiation 
are galactic cosmic rays (GCR) and radiation from solar particles [5]. This space radiation consists of 85% 







Si), and iron (
56
Fe) ions [6]. HZE radiation is of particular concern because it causes 
high linear-energy transfer (high-LET) damage in biological targets and induces repair-refractory 
clustered DNA damage in cells [2, 7-10]. These types of damage directly affect cell survival and genomic 
integrity in surviving cells [11]. In addition, it is estimated that for every cell traversed by a potentially 
lethal HZE nucleus (e.g. 
56
Fe), another 32 cells are hit by δ rays of decreased energy that could induce 
non-lethal mutations [12]. 
56
Fe has been thought to be the most biologically important HZE particles, 
since it may be the single largest naturally occurring particle [6]. 
 
The hematopoietic system is one of the most radiosensitive tissues of the body [13].  Hematopoietic 
stem cells (HSCs) reside in bone marrow (BM) and are responsible for generation and maintenance of 
multiple cell lineages in the blood supply [14]. It is well known that total body irradiation (TBI) affects 
both mature blood cells and hematopoietic stem/progenitor cells and causes both acute radiation 
hematopoietic syndrome and long-term BM injury [15, 16].  HZE particles like 
56
Fe ions have been shown 
to be more toxic than γ rays with lethal doses (LD)50/30 (a radiation dose at which 50% lethality occurs 
at 30-days) of 5.8 Gy compared with 7.25 Gy for γ rays. Mice irradiated with a lethal dose of 
56
Fe showed 
significantly lower white blood cell (WBC) recovery at 4 weeks post-IR, compared to γ-IR mice [17]. 
56
Fe-
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tIR caused loss of hematopoietic stem/progenitor cells immediately after IR, which was maintained for 
up to 8 weeks [18]. In addition, protons, 
28
Si ions and 
56
Fe ions are also known to induce hematopoietic 
malignancies such as acute myeloid leukemia (AML), though not necessarily with greater efficiency than 
γ irradiation [19, 20]. 
 
Exposure of mice to 1 Gy 
56
Fe results in highly complex chromosome aberrations, including dicentrics, as 
well as translocations, insertions and acentric fragments, which is unlike the damage from γ radiation. 
Cells exhibiting these aberrations disappear rapidly after exposure, probably as a result of death of 
heavily damaged cells.  Cells with apparently simple exchanges as their only aberrations, appear to 
survive longer than heavily damaged cells. Eight weeks after exposure, the frequency of cells showing 
cytogenetic damage was reduced to less than 20% of the levels evident at 1 week. These results indicate 
that exposure to 1 Gy 
56
Fe produces heavily damaged cells, a small fraction of which appear to be 
capable of surviving for relatively long periods [21, 22]. In addition, exposure to low doses of 
56
Fe 
resulted in significant epigenetic alterations involving methylation of DNA, and expression of repetitive 
elements, which is also unique to high LET radiation [23]. Therefore, while damage from terrestrial γ 
radiation and X-rays forms the basis our understanding of cellular responses to DNA damage, GCR 
provides a unique cellular stress and highlights gaps in current models describing the response of 
biological systems to space radiation. 
 
IR causes not only DNA strand breaks, but also nucleotide base and sugar damage [24]. Analyses of 
gamma ray and 
56
Fe induced murine AML samples have identified similar molecular changes, including 
biallelic loss and/or mutation of PU.1. Microsatellite instability (MSI), a commonly observed marker of 
DNA mismatch repair (MMR) deficiency, has been observed in 42% of AML samples induced by gamma 
rays or 
56
Fe [25]. MMR is an essential DNA repair pathway responsible for maintaining genomic integrity 
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tprimarily by removing base mismatches and small insertion/deletion loops (IDLs) introduced during 
replication or under genomic stress [26]. In humans, MMR gene defects (most notably in the MLH1, 
MSH2, MSH6, PMS2 genes) and MSI have been most closely associated with Lynch Syndrome [27-29], 
but are also found in an increasing number of tumor types [30].  MMR deficiency has also been 
identified in primary and secondary hematopoietic malignancies and in leukemia and lymphoma cell 
lines [31-33]. Exposure of MMR-deficient mice to gamma radiation results in hypermutability compared 
to wild type  mice, and much of this hypermutability can be attributed to induced instability of simple 
sequence repeats [34]. Interestingly, recent results from our laboratory have demonstrated that 
acquired MMR deficiency and increased MSI in human hematopoietic stem and progenitor cells is age-
related, attributable to progressive loss of Mlh1 through promoter hypermethylation [35, 36]. The data 
show that as many as 30% of HSCs in healthy individuals have lost MLH1 by 45 years of age, which is well 
within the age range of current and former astronauts.  Therefore, TBI may pose an unappreciated risk 
to astronauts on deep space missions if they have significant numbers of MMR defective HSCs. 
 
Though the effects of protons and HZE ions on normal mouse hematopoietic systems have been 
characterized at the effector cell level [17, 37], the impacts on HSC function are not fully known. 
Importantly, in humans demonstrating diminished MMR capacity, the potential for loss of HSC function 
and/or malignant transformation may be greater [35]. Therefore, the role of MMR in response to γ and 
GCR radiation damage needs to be carefully examined. In this study, we used Mlh1-deficient mice to 
investigate the importance of the MMR system on the response of HSCs to protons and 
56
Fe, in 
comparison to γ radiation, with an aim to investigate the risk of hematopoietic failure in astronauts on 
deep space missions. In short, we find that while heavy ions are more damaging than gamma radiation 
to HSC functionality, no additional deficits in hematopoietic function were identified.  The data suggest 
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tthat the greater risk of MMR deficient HSCs likely lies in malignant transformation rather than 
hematopoietic failure. 
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/BoyCrCrl (BoyJ, CD45.1) mice were obtained from Charles River Laboratory. All the 
mice were group-housed in ventilated microisolator cages in a specific pathogen-free facility.  Mice had 
ad libitum access to food (Laboratory Rodent Diet 5LOD, Lab Diet, St. Louis, MO) and water. The animal 
housing room was maintained on a 12:12h light:dark cycle and constant temperature (72 ± 2˚ F). Male 
and female mice between 8 and 16 weeks of age were used for the study. All mouse studies were 
approved
 
by the Institutional Animal Care and Use Committee at Case Western
 
Reserve University 
(Cleveland, OH), and Brookhaven National Laboratory (BNL) (Upton, NY). 
 
Radiation:   




 mice were used for the study. Proton 
and 
56
Fe irradiation were performed at the NASA Space Radiation Laboratory (NSRL) at Brookhaven 
National Laboratories. After 7 days of acclimation, the mice were exposed to TBI with 1 Gy of protons 
(1000 Me/V) or 
56
Fe (600 MeV/n). Gamma irradiations were performed at BNL using a 
137





 animals, and at Case Western Reserve University for recipient mice irradiated with 





 mice was used to compare 
1
H ion and 
56





 mice were used to compare γ-ray irradiated mice because they were 
exposed on different trips to Brookhaven National Laboratory. 
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tPeripheral Blood and BM Collection 
Peripheral blood (PB) was collected from the submandibular vein using a heparinized hematocrit 
capillary tube.  Complete blood count was measured by a Hemavet 950 FS that gives 5-part 
differentiation with 20 parameters. For BM collection, mice were sacrificed roughly three months after 
radiation exposure, the femur and tibia were harvested and immediately flushed with Phosphate-
buffered saline (PBS) containing 2% fetal bovine serum (FBS) using 21 and 27-gauge needles and 
syringes to collect the BM. The number of BM cells was counted using a hemocytometer. 
 
Colony-forming unit (CFU) assays  
BM mononuclear cells (BM-MNCs) were cultured in methylcellulose medium containing cytokines, 
including mouse interleukin 3, human interleukin 6, mouse stem cell factor, and human erythropoietin, 
MethoCult GF M3434 (Stem Cell Technologies, Vancouver, BC). Total numbers of CFU colonies were 
scored on day 7, according to the manufacturer’s protocol. Two separate experiments of three plates 




Flow cytometry was performed
 
on a BD LSRII (BD Biosciences, San Jose, CA), and data
 
were analyzed 
using FlowJo software (TreeStar, Ashland, OR). Antibodies include CD45.2 (clone 104), CD45.1 (clone 
A20), Ly-6G (Gr-1, clone RB6-8C5), CD11b
 
(Mac-1, clone M1/70), CD45R/B220 (clone RA3-6B2), CD3 
(clone 500A2), and Ter119/Ly76 (clone Ter-119), Sca1 (Ly-6A/E, clone D7), c-Kit (CD117, clone 2B8), 
CD48 (clone HM48-1, BD Bioscience) and CD150 (clone TC15-12F12.2, Biolegend, San Diego, CA).  
 
Competitive repopulation assay 
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tAll mice were sacrificed roughly three months post radiation exposure and BM cells were collected for 
competitive repopulation assay. 2x10
6
 BM cells from mice (CD45.2) of each genotype were mixed with 
the same number of wild type (CD45.1) competitor BM and transplanted into lethally irradiated (11Gy) 
BoyJ recipients (CD45.1) through lateral tail veins. The recipients were monitored and analyzed for 
hematopoietic reconstitution and lymphoma development. Peripheral blood was collected 8 weeks and 




Statistical analysis was performed using GraphPad 5.0. Student’s t tests were used to determine the 
significance of pairwise comparisons; ANOVA were used for dose response analyses, and log-rank tests 
were used to analyze survival curves.  p<0.05 was the measure of statistical significance.  
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High LET radiation induces similar long term damage to the bone marrow as γ radiation. 
In order to begin to assess the effects of high LET radiation on MMR defective HSCs, we first sought to 
establish the effects of 
56
Fe compared to γ radiation on stem cell function.  Various studies in the 
literature have demonstrated that 
56
Fe and other high LET sources can damage hematopoiesis with 
different relative biological effectiveness (RBE) [17, 38].  We thus assessed bone marrow cellularity; 
enumerated Sca1+, c-Kit+, Lin- (SKL) cells; measured proliferation; and determined repopulation 
capacity all at a latent time point.  As seen in figure 1A, at three months after exposure to 1 Gy of γ or 
56
Fe radiation, bone marrow cellularity was unchanged in the animals compared to control animals.  In 
contrast, the SKL populations in the animals dropped by greater than 50% in both the γ and 
56
Fe groups.  
Notably, there was no significant difference between the two radiation sources.  HSCs are known to 
rapidly reenter the cell cycle from quiescence in response to hematopoietic stresses in order to regain 
homeostasis.  By three months, however, both the irradiated cohorts displayed HSC proliferation that 
was identical to the non-irradiated animals, as evidenced by BrdU incorporation (Figure 1C).  The 
behavior was similar with the broader SKL population as well as the more primitive CD48- SKL cells.  
Finally, we measured the functionality of the irradiated HSCs by performing a competitive 
transplantati n assay using unirradiated marrow injected into lethally irradiated hosts.  We observed 
that the irradiated marrow was functionally challenged and had grafting potential that was reduced 
nearly 50% in both γ and 
56
Fe cohorts, indicating similar RBEs at the 1 Gy dose (Figure 1D).  With these 
data in hand, we could now address the role of MMR function. 
High LET radiation is more damaging to clonogenic capacity of stem cells than low LET radiation, but 
independent of MMR status. 
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tExposure of HSCs to multiple forms of ionizing radiation, including space radiation, is known to reduce 
clonogenic capacity [18]. To determine whether loss of MMR plays a role in BM vitality after exposure to 
γ, protons (1000 MeV/n) or 
56
Fe radiation (600 MeV/n), clonogenic assays were performed on isolated 
bone marrow in a standard colony forming assay.  As expected, high LET radiation effected a greater 
decrease in colony formation than γ or proton radiation across a range of doses from 0.1 to 2.5 Gy 
(Figure 2A-C).  In addition, 
56
Fe ion exposure clearly caused a greater decrease in the number of BFU-E 
and CFU-GM than low LET γ or proton radiation (supplementary figure 1A-1I). We did not, however 
observe significant differences between the wild type and Mlh1 knockout marrow, suggesting that MMR 
function does not contribute to acute effects of IR on clonogenicity in vitro. 
 
Blood counts demonstrate similar acute damage to the hematopoietic system across LET.  
 
To assess the acute effects of IR on MMR competent and deficient marrow in vivo, we performed TBI 
with γ, protons or 
56
Fe at 1 Gy, and performed regular blood counts for up to 30 days.  The response of 
specific effector cells to IR has been well documented, with lymphocytes being the most sensitive cells.  
As seen in Figure 3A-C, total WBCs displayed significantly more sensitivity to any form of IR compared 
with red blood cells and platelets (Figure 3D-I), which here did not decrease substantially during the 30-
day follow up.  There were no significant differences between the different radiation sources, however, 
all three effected similar transient decreases in lymphocytes (supplementary figure 2A-2C).  Again, no 
differences were observed between Mlh1 competent and deficient marrow. 
 
Long term effects on hematopoiesis by IR is independent of MMR status. 
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tIn order to assess latent or long term effects of high and low LET radiation on hematopoiesis, TBI was 
performed on cohorts of both wild type and Mlh1
-/-
 mice with 1 or 2.5 Gy of γ radiation, 1 Gy of proton 
radiation, or 1 Gy of 
56
Fe.  Three months after exposure, we planned to analyze the frequencies and 
numbers of different hematopoietic cell populations in BM by flow cytometry, and measure HSC 
functionality by transplantation assays.  We first, however, noted survival statistics of the cohorts.  As 
previously published, Mlh1
-/-
 animals are tumor prone, with lymphomas and gastrointestinal tumors 
being the most prevalent malignancies [39] and γ irradiation of Mlh1 deficient mice is known to 
accelerate tumorigenesis [40].  With a three-month follow-up, we found that 43% of the null animals 
developed malignancy while none of the control, wild type mice developed any tumors.  To break the 
numbers down by treatment group, 19% (4 of 21) unirradiated null mice, 64% (7 of 11) 1 Gy γ irradiated 
mice, 45% (5 of 11) 2.5 Gy γ irradiated mice, 33% (3 of 10) of 1 Gy proton irradiate mice, and 30% (3 of 9) 
1 Gy 
56
Fe irradiated mice were euthanized for morbidity due to tumor formation within three months 
after exposure (Figure 4A-C).  The only statistically significant increase in malignancy was in the 1 Gy γ 
group (p=0.0155, Log-rank). Presumably, had the animals been given longer times to develop tumors, as 
has been done in other studies, our data would have shown increased tumorigenesis in the other 
radiation groups as well.  Additionally, we found only lymphomas in our cohorts, also likely due to the 
short follow up, as found previously [40]. 
 
Our primary interest was in determining the function of the MMR-defective HSCs at extended times 
after radiation.  Therefore, at three months after exposure, all surviving mice were euthanized, and 
marrow was harvested and assessed.  We first quantified the SKL cells.  As seen in Figure 5A-C, γ, proton, 
and 
56
Fe irradiated animals demonstrated significant decreases in SKL cells compared to unirradiated 
control mice.  The γ irradiated animals displayed dose dependent decreases in SKL cells of up to 56% of 
non-irradiated animals at 2.5 Gy (p<0.0001 for Mlh1
+/+
, and p=0.0002 for Mlh1
-/-
; one-way ANOVA).  In 
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tpairwise comparisons, we noted that unlike the wild type mice, the Mlh1-/- null mice did not show 
significantly reduced SKL cells in the marrow at the 1 Gy dose, potentially suggesting protection against 
IR (p<0.0001 for wild type, p=0.25 for Mlh1
-/-
; student’s t tests); but any protection was lost at the higher 
dose where both genotypes were similar.  Likewise, proton radiation led to a significant decrease in SKL 
cells in the wild type (p<0.0001, student’s t test), and Mlh1
-/-
 animals (p<0.0001, student’s t test). 
56
Fe 
irradiation resulted in indistinguishable decreases of SKL cells in both genotypes (p<0.05 for both, 





(supplementary figure 3). In summary, three months after IR, significant decreases can be observed in 
SKL cell numbers in the bone marrow of exposed mice, but Mlh1 function does not appear to play a role 
in this response.   
 
We next looked at hematopoietic progenitor cells (HPCs) by gating for Sca1-, c-Kit+, Lin− cells.  Here we 
observed that there were no detectable differences in any of the radiation source groups, at any dose, 
and for either genotype (Figure 5D-F). These data suggest that the SKL cells that remain functional three 
months after IR are sufficient to produce the normal levels of progenitor cells that are required to 
maintain the hematopoietic system.  
 
Finally, we tested the colony forming potential of the marrow in standard CFU assays, by embedding 
bone marrow derived cells in methylcellulose with a variety of stem cell cytokines and enumerating 
colonies after 7 days (Figure 5G-H).  In agreement with our observations of SKL cells, we found that γ 
radiation led to statistically significant drops in CFU in a dose dependent manner for both genotypes 
(p<0.0001 for wild type and Mlh1
-/-
, ANOVA).  For proton radiation at 1 Gy, both genotypes displayed 
significant drops in CFU, 26.8% for wild type (p<0.0001, student’s t test) and 31.6% for Mlh1
-/-
, (p<0.0001 
student’s t test).  Surprisingly, 
56
Fe radiation did not cause any measureable defects in clonogenic 
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tcapacity, which is in contrast to the observed effects on SKL cells, and could be due to an iron specific 
hyperproliferation in the SKLs.  Importantly, all of the observed effects were independent of Mlh1 status. 
 
Defects in Mlh1 function do not enhance decreased competitive repopulation caused by IR 
As a long term, functional measure of hematopoiesis, we conducted competitive repopulation studies 
comparing irradiated marrow of each genotype to wild type, unirradiated marrow.  The concept is that if 
long term functional defects exist, the irradiated and/or Mlh1 defective marrow will contribute less 
efficiently to repopulation of the marrow after lethal IR, and can be demonstrated by flow cytometry of 
peripheral blood  [41, 42]. We therefore mixed competitor bone marrow cells from CD45.1 mice at a 1:1 
ratio with irradiated wild type, or Mlh1
-/-
 marrow from each irradiation exposure, and transplanted the 
cells into lethally irradiated hosts.  At 8 and 16 weeks after transplant, peripheral blood was analyzed 
and revealed marked decreases in competition of the irradiated marrow from all sources.  Much like we 
observed with the SKL data, γ irradiation led to a dose dependent decrease in competition from 1 and 
2.5 Gy (p<0.0001, ANOVA) treated mice of both genotypes, at both 8 and 16 weeks (Figure 6A, B). For 
proton irradiation, similar decreases were seen with 1 Gy in both genotypes, at both time points (Figure 
6C, D), and no differences were observed between the genotypes.  Finally, we tested the 
56
Fe irradiated 
marrow and found reduced but consistent effects of IR on the marrow functionality (Figure 6E).  
Together the data confirm that long term damage occurs after low and high LET radiation, but that Mlh1 
status is inconsequential to the function of the marrow. 
Discussion: 
 
In the current study, we investigated the effects of low and high LET IR on HSCs in vitro and in vivo with 
the goal of evaluating the significance of MMR defects that are characteristic of aging individuals who 
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tcould be exposed during space travel.  We found primarily that MMR, as a function of Mlh1 gene 
presence or absence, is not a relevant factor for hematopoietic functionality after radiation.  We 
assessed clonogenic capacity of bone marrow harvested immediately after irradiation, as well as 
clonogenic capacity in marrow harvested three months after irradiation with γ, proton or 
56
Fe sources 
and found almost identical responses, regardless of Mlh1 status.  We assessed blood counts of the 
animals for up to 30 days post exposure and similarly found that Mlh1 wild type and knock out animals 
responded indistinguishably.  Finally, we assessed SKL cells and HPCs in the bone marrow at three 
months after exposure, and also measured transplantability of the bone marrow at three months and 
found notable decreases in stem cell number and function due to radiation, but not due to Mlh1 status. 
Together the data support the conclusion that MMR status is not a relevant variable for function of the 
hematopoietic system after exposure to γ or space radiation, and thus does not contribute added risk to 
astronauts. 
 
Effective DNA repair is an essential function for the fidelity of organisms.  HSCs are no exception to this 
rule, and indeed it has been elegantly shown that HSCs that lack efficient repair as they age, through 
loss of Ligase IV or Ku70, and thus non-homologous end joining, display reduced hematopoietic stem 
cell functions [43, 44].  Studies of animals engineered to harbor defective nucleotide excision repair or 
telomere maintenance show similar age-associated defects [43].  However, defects in these major repair 
pathways, unlike MMR defects, are relatively low in frequency [35, 45].  Ionizing radiation poses a 
greater threat to HSC biology due to the relative facility of exposure in modern society, and the exquisite 
sensitivity of the HSCs to DNA damaging stress [46].  Clearly, the combination of DNA repair defects, in 
the presence of IR stress would be predicted to compromise HSC functions even further.  
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tTissue kinetics contribute significantly to the time of manifestation of radiation induced damage.  The 
hematopoietic system is extremely sensitive to ionizing radiation, demonstrating depletion of functional 
cells within hours to days [47], and an associated proliferative response of progenitor cells in the same 
time frame [48].  Latent tissue damage, however, implies depletion of stem cells, or a continued source 
of cell stress that prolongs damage manifestation.  In the current studies, both explanations are likely to 
contribute. We observed depletion of HSCs three months after exposure, as well as decreased 
repopulation capacity of the remaining stem cells in a competitive transplant assay.  Previously, elevated 
levels of reactive oxygen species correlating with decreased HSCs have been observed at 22 weeks after 
exposure to proton radiation, in line with our observations here [49]. Added mutational load, which is 
known to occur with MMR defects and radiation exposure [34], however, did not exacerbate the latent 
phenotype, at least regarding HSC function.  While we measured functional cells by complete blood 
counts and found no effect of Mlh1 status, it is possible that some lineage differences exist that were 
not detected.  Most notably, though, decreased stem cell function at latent times could be due to stem 
cell exhaustion caused by excessive induced proliferation in the acute phase immediately after exposure, 
and remains a risk to hematopoiesis that is shown here to be independent of MMR function. 
 
Therefore, the predominant additional risk to the hematopoietic system of MMR defective individuals is 
likely to remain in the development of malignancies.  The identification of MMR defective cancers  
outside of the gastrointestinal family in which they were first appreciated continues to rise, highlighting 
the importance of MMR to tumor suppression [30, 50]. Further studies will be required to assess the 
role of Mlh1 loss in the carcinogenic process in the hematopoietic lineages to most accurately assess risk 
for the purposes of deep space missions. 
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Figure 1:  Low and high LET radiation have similar effects on hematopoiesis at 3 months post IR.  Bone 
marrow cellularity (A), SKL numbers (B), and HSC proliferation (C) as measured by BrdU incorporation at 
three months post exposure to 1 Gy of γ or 
56
Fe.  (D) Competitive transplantation assay of marrow 
harvested from irradiated cohorts at three months against unirradiated healthy marrow. 
 
Figure 2:  MMR status does not contribute to clonogenic capacity of HSCs after radiation.  γ (A), proton 
(B), and 
56
Fe (C) irradiated wild type and Mlh1 knockout BM cells in CFU assays after exposure to 0.1, 0.5, 
1, or 2.5 Gy of radiation (n=6, number of plates used for each radiation exposure). 
Figure 3:  Blood counts of wild type and Mlh1 knockout animals demonstrate radiation induced changes, 
but no Mlh1 associated defects.  Complete blood counts were performed at 10 days prior to, and 2, 10, 
20, and 30 days after exposure to indicated doses of γ (A, D, G), proton (B, E, H) or 
56
Fe (C, F, I) sources.  





 mice used for each radiation exposure). 
Figure 4:  Mlh1 knockout mice display enhanced sensitivity to ionizing radiation. Survival plots of cohorts 
of mice of wild type or Mlh1 knockout genotypes exposed to 1 Gy of γ (A), proton (B), or 
56
Fe (C) 




 mice used for each radiation exposure). 
Figure 5:  Latent effects of radiation are independent of MMR status.  Quantification of SKL cells in wild 
type and Mlh1 deficient animals three months after exposure to γ (A), proton (B), and 
56
Fe (C) radiation 
at indicated doses.  Quantification of HPC cells in wild type and Mlh1 deficient animals three months 
after exposure to γ (D), proton (E), and 
56
Fe (F) radiation at indicated doses.  Quantification of colony 
formation of bone marrow preparations in wild type and Mlh1 deficient animals three months after 
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texposure to γ (G), proton (H), and 56Fe (I) radiation at indicated doses.  Marrow was collected from 
between 4 and 12 animals. 
Figure 6:  Radiation, but not Mlh1 deficiency, reduces competitive capacity of the bone marrow after 
exposure.  Measurement of % contribution of CD45.2 positive cells to peripheral blood at 8 (A, C, and E) 
and 16 (B and D) weeks after competitive transplant of 1 Gy of γ (A and B), proton (C and D), and 
56
Fe (E) 
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Supplementary figure 1: Myeloid CFU survival post radiation exposure. (A-C) Number of total myeloid CFU, BFU-E, and 
CFU-GM post different doses of gamma-rays IR. (D-F) Number of total myeloid CFU, BFU-E, and CFU-GM post different 
doses of proton ion IR. (G-I) Number of total myeloid CFU, BFU-E, and CFU-GM post different doses of 56Fe ion IR. 
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Supplementary figure 2: Lymphocyte counts in Mlh1+/+ and Mlh1-/- mice pre and post (A) γ-rays IR, (B) 1H ion IR, and (C) 
56Fe ion IR. 
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Supplementary figure 3: Bone marrow cellularity three months after exposure to IR is unchanged in control and 
Mlh1-/- animals. 
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t   
 
 
The hematopoietic system is essential for life, and normally has the capacity to sustain function for the 
duration of our lifetimes in spite of natural declination, which is associated with loss of DNA repair (including 
as DNA mismatch repair (MMR).  Astronauts are exposed to ionizing radiation sources that are not 
commonly found on earth (such as HZE ions) and thus may display unforseen risks that need accounting in 
NASA risk models.  
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